Patents by Inventor Richard F. Schroeder
Richard F. Schroeder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20040225304Abstract: A method for placing a splint assembly transverse a heart chamber includes providing an elongate member having a first end and a second end and a deployable heart-engaging assembly connected to at least the first end. The method includes advancing the elongate member through vasculature structure and into the heart chamber such that the first end of the elongate member extends through a first location of a wall surrounding the heart chamber and the second end extends through a second location of the heart chamber wall substantially opposite the first location. A deployable heart-engaging assembly is deployed such that it engages with a first exterior surface portion of the heart chamber wall adjacent the first location. The elongate member is secured with respect to the heart with a second heart-engaging assembly connected to the second end. The second heart-engaging assembly engages with a second exterior surface portion of the heart chamber wall adjacent the second location.Type: ApplicationFiled: December 12, 2003Publication date: November 11, 2004Applicant: MyocorInventors: Robert M. Vidlund, Marc A. Simmon, Todd J. Mortier, Cyril J. Schweich, Peter T. Keith, Richard F. Schroeder, Jason Kalgreen
-
Publication number: 20040152947Abstract: The various aspects of the invention pertain to devices and related methods for treating heart conditions, including, for example, dilatation, valve incompetencies, including mitral valve leakage, and other similar heart failure conditions. The devices and related methods of the present invention operate to assist in the apposition of heart valve leaflets to improve valve function. According to one aspect of the invention, a method improves the function of a valve of a heart by placing an elongate member transverse a heart chamber so that each end of the elongate member extends through a wall of the heart, and placing first and second anchoring members external the chamber. The first and second anchoring members are attached to first and second ends of the elongate member to fix the elongate member in a position across the chamber so as to reposition papillary muscles within the chamber.Type: ApplicationFiled: January 23, 2004Publication date: August 5, 2004Inventors: Richard F. Schroeder, Robert M. Vidlund, Jason E. Kalgreen, Cyril J. Schweich, Todd J. Mortier
-
Patent number: 6723038Abstract: Devices and related methods for treating heart conditions, including, for example, dilatation, valve incompetencies, including mitral valve leakage, and other heart failure conditions, may operate to assist in the apposition of heart valve leaflets to improve valve function. A method for improving the function of a valve of a heart includes placing an elongate member transverse a heart chamber so that each end of the elongate member extends through a wall of the heart, and placing first and second anchoring members external the chamber. The first and second anchoring members are attached to first and second ends of the elongate member to fix the elongate member in a position across the chamber so as to reposition papillary muscles within the chamber. A method of treating the valve may include real-time monitoring the valve function and adjusting the device based on data obtained during the real-time monitoring.Type: GrantFiled: October 6, 2000Date of Patent: April 20, 2004Assignee: Myocor, Inc.Inventors: Richard F. Schroeder, Robert M. Vidlund, Jason E. Kalgreen, Cyril J. Schweich, Jr., Todd J. Mortler
-
Publication number: 20030181928Abstract: A method for placing a splint assembly transverse a heart chamber includes providing an elongate member having a first end and a second end and a deployable heart-engaging assembly connected to at least the first end. The method includes advancing the elongate member through vasculature structure and into the heart chamber such that the first end of the elongate member extends through a first location of a wall surrounding the heart chamber and the second end extends through a second location of the heart chamber wall substantially opposite the first location. A deployable heart-engaging assembly is deployed such that it engages with a first exterior surface portion of the heart chamber wall adjacent the first location. The elongate member is secured with respect to the heart with a second heart-engaging assembly connected to the second end. The second heart-engaging assembly engages with a second exterior surface portion of the heart chamber wall adjacent the second location.Type: ApplicationFiled: April 10, 2003Publication date: September 25, 2003Applicant: Myocor, Inc.Inventors: Robert M. Vidlund, Marc Simmon, Todd Mortier, Cyril J. Schweich, Peter T. Keith, Richard F. Schroeder, Jason Kalgreen
-
Patent number: 6616684Abstract: A method for placing a splint assembly transverse a heart chamber includes providing an elongate member having a first end and a second end and a deployable heart-engaging assembly connected to at least the first end. The method includes advancing the elongate member through vasculature structure and into the heart chamber such that the first end of the elongate member extends through a first location of a wall surrounding the heart chamber and the second end extends through a second location of the heart chamber wall substantially opposite the first location. A deployable heart-engaging assembly is deployed such that it engages with a first exterior surface portion of the heart chamber wall adjacent the first location. The elongate member is secured with respect to the heart with a second heart-engaging assembly connected to the second end. The second heart-engaging assembly engages with a second exterior surface portion of the heart chamber wall adjacent the second location.Type: GrantFiled: October 6, 2000Date of Patent: September 9, 2003Assignee: Myocor, Inc.Inventors: Robert M. Vidlund, Marc A. Simmon, Todd J. Mortier, Cyril J. Schweich, Jr., Peter T. Keith, Richard F. Schroeder, Jason Kalgreen
-
Patent number: 6613087Abstract: A prosthetic stentless aortic tissue valve includes a substantially annular valve body having a leaflet carried therein for occluding blood flow therethrough. A root extends generally coaxially from the valve body. Visual marking are provided on the root and act as a sculpting guide for a surgeon during implantation of the prosthetic heart valve to sculpt portions of sinus areas of the root.Type: GrantFiled: June 6, 2000Date of Patent: September 2, 2003Assignee: St. Jude Medical, Inc.Inventors: Steven J. Healy, Richard F. Schroeder
-
Patent number: 6537198Abstract: A splint assembly for placement transverse a heart chamber to reduce the heart chamber radius and improve cardiac function has a tension member formed of a braided cable with a covering. A fixed anchor assembly is attached to one end of the tension member and a leader for penetrating a heart wall and guiding the tension member through the heart is attached to the other end. An adjustable anchor assembly can be secured onto the tension member opposite to the side on which the fixed pad assembly is attached. The adjustable anchor assembly can be positioned along the tension member so as to adjust the length of the tension member extending between the fixed and adjustable anchor assemblies. The pad assemblies engage with the outside of the heart wall to hold the tension member in place transverse the heart chamber. A probe and marker delivery device is used to identify locations on the heart wall to place the splint assembly such that it will not interfere with internal heart structures.Type: GrantFiled: March 21, 2000Date of Patent: March 25, 2003Assignee: Myocor, Inc.Inventors: Robert M. Vidlund, Thomas M. Paulson, Todd J. Mortier, Cyril J. Schweich, Jr., Richard F. Schroeder
-
Publication number: 20030050529Abstract: A splint assembly for placement transverse a heart chamber to reduce the heart chamber radius and improve cardiac function has a tension member formed of a braided cable with a covering. A fixed anchor assembly is attached to one end of the tension member and a leader for penetrating a heart wall and guiding the tension member through the heart is attached to the other end. An adjustable anchor assembly can be secured onto the tension member opposite to the side on which the fixed pad assembly is attached. The adjustable anchor assembly can be positioned along the tension member so as to adjust the length of the tension member extending between the fixed and adjustable anchor assemblies. The pad assemblies engage with the outside of the heart wall to hold the tension member in place transverse the heart chamber. A probe and marker delivery device is used to identify locations on the heart wall to place the splint assembly such that it will not interfere with internal heart structures.Type: ApplicationFiled: October 24, 2002Publication date: March 13, 2003Applicant: Myocor, Inc.Inventors: Robert M. Vidlund, Thomas M. Paulson, Todd J. Mortier, Cyril J. Schweich, Jeffrey P. LaPlante, David A. Kusz, Richard F. Schroeder
-
Patent number: 6531310Abstract: A method is disclosed for processing tissue by inoculating the tissue with a solution having microorganisms, where the microorganisms are selected to produce compounds that process the tissue. The tissue is incubated with the inoculated microorganisms under conditions that are effective for processing the tissue by the chemicals produced by the microorganisms. The tissue maybe subsequently treated to substantially remove or inactivate the microorganisms.Type: GrantFiled: July 3, 2000Date of Patent: March 11, 2003Assignee: St. Jude Medical, Inc.Inventors: M. William Mirsch, II, Richard F. Schroeder, William H. Borner, Susan I. Montoya
-
Patent number: 6497725Abstract: An apparatus is disclosed for differentially treating a medical device. One portion of the device is treated with a first fluid and a separate portion is treated with a second fluid. The second fluid generally is substantially different from the first fluid. The first fluid can be contacted with an flow region of the medical device. The apparatus can include a conduit system, where fluid flowing through the conduit system flows through the flow region. Sheet material can be treated differentially on the opposite surfaces of the sheet. The medical device can include vascular tissue.Type: GrantFiled: March 9, 2001Date of Patent: December 24, 2002Assignee: St. Jude Medical, Inc.Inventors: R. Brian Williams, Richard F. Schroeder, Matthew F. Ogle
-
Patent number: 6322588Abstract: Medical devices are formed from metal/polymer composites that have improved characteristics. The metal/polymer composites have a relatively thick metal coating with an average metal thickness of greater than about 3 microns. The composite has mechanical properties, such as mechanical strength, durability and resiliency, contributed by the metal coating. The metal/polymer composites can be formed by solution based or vapor based approaches.Type: GrantFiled: August 17, 1999Date of Patent: November 27, 2001Assignee: St. Jude Medical, Inc.Inventors: Matthew F. Ogle, Matthew S. Reimink, Richard F. Schroeder
-
Patent number: 6302909Abstract: The invention involves a bioprosthetic article including a biocompatible material having at least one bound exogenous storage structure, the storage structures having collectively greater than about 0.5 mg metal cations per gram of biocompatible material. The calcification inhibitors preferably decrease calcium deposition by greater than 95% relative to untreated tissue. The calcification inhibitors are bonded to the bioprosthetic material preferably at a pH between about 6.0 and 8.5.Type: GrantFiled: July 31, 1996Date of Patent: October 16, 2001Assignee: St. Jude Medical, Inc.Inventors: Matthew F. Ogle, Richard F. Schroeder
-
Publication number: 20010020191Abstract: An apparatus is disclosed for differentially treating a medical device. One portion of the device is treated with a first fluid and a separate portion is treated with a second fluid. The second fluid generally is substantially different from the first fluid. The first fluid can be contacted with an flow region of the medical device. The apparatus can include a conduit system, where fluid flowing through the conduit system flows through the flow region. Sheet material can be treated differentially on the opposite surfaces of the sheet. The medical device can include vascular tissue.Type: ApplicationFiled: March 9, 2001Publication date: September 6, 2001Inventors: R. Brian Williams, Richard F. Schroeder, Matthew F. Ogle
-
Patent number: 6267782Abstract: A variety of new ways can be used for associating antimicrobial elemental metal with a medical article. The associated antimicrobial metal reduces the risk of infection associated with the medical use of the medical article. New medical articles are produced by some of these new approaches. Some of the methods involve ways of adjusting the dissociation rate of associated elemental metal such that desired degrees of antimicrobial activity can be achieved over selected periods of time.Type: GrantFiled: August 31, 1998Date of Patent: July 31, 2001Assignee: St. Jude Medical, Inc.Inventors: Matthew F. Ogle, William R. Holmberg, Richard F. Schroeder, Donald S. Guzik, M. William Mirsch, II, Darrin J. Bergman, Hallie A. Finucane, Katherine S. Tweden
-
Patent number: 6254635Abstract: Medical articles can include biocompatible material with a deposit of anticalcific elemental metal. The biocompatible material can be tissue, fabric or the like. The biocompatible material can be configured on the medical article such that when the medical article is positioned for its intended use, the biocompatible material is substantially removed from blood flow or is in a low blood flow area effectively removed from vascular blood flow. Gas phase or solution phase methods can be used to deposit the anticalcific elemental metal.Type: GrantFiled: February 2, 1998Date of Patent: July 3, 2001Assignee: St. Jude Medical, Inc.Inventors: Richard F. Schroeder, Matthew F. Ogle
-
Patent number: 6206917Abstract: An apparatus is disclosed for differentially treating a medical device. One portion of the device is treated with a first fluid and a separate portion is treated with a second fluid. The second fluid generally is substantially different from the first fluid. The first fluid can be contacted with an flow region of the medical device. The apparatus can include a conduit system, where fluid flowing through the conduit system flows through the flow region. Sheet material can be treated differentially on the opposite surfaces of the sheet. The medical device can include vascular tissue.Type: GrantFiled: May 2, 1997Date of Patent: March 27, 2001Assignee: St. Jude Medical, Inc.Inventors: R. Brian Williams, Richard F. Schroeder, Matthew F. Ogle
-
Patent number: 6193749Abstract: In general, the invention features a bioprosthetic article including a biocompatible material having at least one bound exogenous storage structure, the storage structure having a quantity of calcification inhibitors releasably bound thereto. The storage structure can be a protein or a synthetic polymer. The calcification inhibitors include metal ions and phosphatase inhibitors generally. Bifunctional metal chelators can be bound to endogenous proteins to deliver metal ions.Type: GrantFiled: September 17, 1997Date of Patent: February 27, 2001Assignee: St. Jude Medical, Inc.Inventors: Richard F. Schroeder, Matthew F. Ogle
-
Patent number: 6190407Abstract: A variety of new ways can be used for associating antimicrobial elemental metal with a medical article. The associated antimicrobial metal reduces the risk of infection associated with the medical use of the medical article. New medical articles are produced by some of these new approaches. Some of the methods involve ways of adjusting the dissociation rate of associated elemental metal such that desired degrees of antimicrobial activity can be achieved over selected periods of time.Type: GrantFiled: December 31, 1998Date of Patent: February 20, 2001Assignee: St. Jude Medical, Inc.Inventors: Matthew F. Ogle, William R. Holmberg, Richard F. Schroeder, Donald S. Guzik, M. William Mirsch, II, Darrin J. Bergman, Hallie A. Finucane, Katherine S. Tweden
-
Patent number: 6132473Abstract: An apparatus is disclosed for differentially treating a medical device. One portion of the device is treated with a first fluid and a separate portion is treated with a second fluid. The second fluid generally is substantially different from the first fluid. The first fluid can be contacted with an flow region of the medical device. The apparatus can include a conduit system, where fluid flowing through the conduit system flows through the flow region. Sheet material can be treated differentially on the opposite surfaces of the sheet. The medical device can include vascular tissue.Type: GrantFiled: May 28, 1998Date of Patent: October 17, 2000Assignee: St. Jude Medical, Inc.Inventors: R. Brian Williams, Richard F. Schroeder, Matthew F. Ogle
-
Patent number: 6126007Abstract: A tissue valve holder for holding a tissue heart valve bioprosthesis such that the tissue valve may be supported without contacting any surface, regardless of whether or not the valve is in a container. The tissue valve holder includes a holder assembly adapted to be secured to the tissue valve. The holder assembly may include a holder body and a removable disk. The holder assembly and the tissue valve secured thereto rest on a support structure. The support structure may comprise a support surface and a plurality of support legs. The support surface, in turn, may comprise an annular ring with the support legs connected thereto. The holder assembly rests on the support surface with the tissue valve suspended in the center of the ring.Type: GrantFiled: December 30, 1998Date of Patent: October 3, 2000Assignee: St. Jude Medical, Inc.Inventors: Erik E. Kari, Richard F. Schroeder, Jason Kalgreen